Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:01:55 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



News for U:YMAB from 2023-05-18 to 2024-05-17 - 22 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-05-07 16:05U:YMABNews ReleaseY-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
2024-04-26 07:05U:YMABNews ReleaseY-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
2024-04-25 16:05U:YMABNews ReleaseY-mAbs to Present at 2024 ASCO Annual Meeting
2024-03-14 09:05U:YMABNews ReleaseY-mAbs Therapeutics Announces Resignation of Chief Financial Officer
2024-03-04 07:30U:YMABNews ReleaseY-mAbs Appoints Oncology Executive Mary Tagliaferri, M.D. to its Board of Directors
2024-02-29 16:05U:YMABNews ReleaseY-mAbs Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
2024-02-16 07:30U:YMABNews ReleaseY-mAbs to Announce Fourth Quarter and Full Year 2023 Financial and Operating Results on February 29, 2024
2024-01-02 16:05U:YMABNews ReleaseY-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
2023-12-13 16:05U:YMABNews ReleaseY-mAbs Therapeutics Added to the NASDAQ Biotechnology Index
2023-11-13 16:05U:YMABNews ReleaseY-mAbs Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
2023-10-31 07:05U:YMABNews ReleaseY-mAbs to Announce Third Quarter 2023 Financial and Operating Results on November 13, 2023
2023-10-18 16:05U:YMABNews ReleaseY-mAbs Names Michael Rossi as President and Chief Executive Officer and Director
2023-10-17 16:05U:YMABNews ReleaseY-mAbs Therapeutics Announces U.S. FDA Clearance of Investigational New Drug Application for CD38-SADA
2023-10-16 16:05U:YMABNews ReleaseY-mAbs Announces Publication in Cancers
2023-09-21 16:05U:YMABNews ReleaseY-mAbs Announces Data to be Presented at the 55th Congress of the International Society of Pediatric Oncology
2023-09-06 16:05U:YMABNews ReleaseY-mAbs to Participate at Upcoming Investor Conferences in September
2023-08-10 16:05U:YMABNews ReleaseY-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
2023-08-02 16:05U:YMABNews ReleaseY-mAbs to Participate at Upcoming Investor Conferences
2023-08-01 16:05U:YMABNews ReleaseY-mAbs to Announce Second Quarter 2023 Financial and Operating Results on August 10, 2023
2023-05-26 09:00U:YMABNews ReleaseY-mAbs Announces Presentation of Naxitamab Data at ASCO
2023-05-26 09:00U:YMABNews ReleaseY-mAbs Announces Presentation of GD2-SADA Study at ASCO
2023-05-23 09:00U:YMABNews ReleaseY-mAbs ¢ € ™ DANYELZA ‚ ® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma approved in Brazil